A detailed history of First Capital Advisors Group, Llc. transactions in Eli Lilly & CO stock. As of the latest transaction made, First Capital Advisors Group, Llc. holds 475 shares of LLY stock, worth $377,943. This represents 0.12% of its overall portfolio holdings.

Number of Shares
475
Holding current value
$377,943
% of portfolio
0.12%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023

BUY
$350.74 - $468.98 $166,601 - $222,765
475 New
475 $222,000
Q3 2018

Oct 24, 2018

SELL
$85.86 - $107.31 $366,107 - $457,569
-4,264 Closed
0 $0
Q2 2018

Jul 30, 2018

SELL
$75.7 - $86.88 $1,438 - $1,650
-19 Reduced 0.44%
4,264 $364,000
Q1 2018

Apr 11, 2018

SELL
$74.21 - $87.6 $93,207 - $110,025
-1,256 Reduced 22.68%
4,283 $331,000
Q4 2017

Jan 25, 2018

SELL
$81.94 - $87.89 $28,679 - $30,761
-350 Reduced 5.94%
5,539 $0
Q3 2017

Oct 31, 2017

BUY
$77.07 - $85.54 $453,865 - $503,745
5,889
5,889 $504,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track First Capital Advisors Group, Llc. Portfolio

Follow First Capital Advisors Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Capital Advisors Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on First Capital Advisors Group, Llc. with notifications on news.